Podcast Summary: AFP: American Family Physician Podcast

Episode 227 – April 2025 – Part 1
Date: April 16, 2025
Contributors: Dr. Steven Brown, Dr. Valeria Vasquez, Dr. Satyam Patel

Episode Overview

In this episode, the AFP Podcast team from the University of Arizona College of Medicine-Phoenix Family Medicine Residency reviews the April 2025 issue of American Family Physician. They deliver high-yield clinical updates on: labor management, acute migraine treatment, tirzepatide for sleep apnea, options for unintended pregnancies, the evolving role of artificial intelligence scribes, and testosterone replacement in men with sexual dysfunction.

Key Discussion Points

1. Labor Management – New ACOG Guidelines

[00:34–04:02]

• Guideline Source: American College of Obstetrics and Gynecology, summarized by Dr. Hwang and Banks, with a commentary by Dr. Arnold
• Trustworthiness: “This guideline gets 7 out of 8 yes answers on the G Trust Scorecard, so that’s pretty good.” (Steve Brown, 01:57)
• Labor Stages:
  • First Stage:
    • Latent phase: Regular, painful contractions, dilation <6 cm
    • Active phase: Begins at 6 cm dilation
    • Active phase arrest: No dilation after 4 hours with adequate contractions or 6 hours of oxytocin
    • Avoid cesarean for latent phase arrest
  • Second Stage:
    • Starts at 10 cm to delivery
    • Prolonged: >3 hours pushing for nulliparous, >2 hours for multiparous
• Interventions & Recommendations:
  • Neuraxial analgesia (epidural) can be used at any labor stage
  • Early amniotomy shortens labor time with no increase in C-section rates
  • Continuous one-on-one support and upright maternal positions (e.g., sitting or kneeling, "peanut ball") improve outcomes and reduce C-sections
  • In second stage, immediate pushing is preferred to “laboring down”
• Quote:

  "Upright maternal positions like sitting or kneeling may reduce the duration of the first stage of labor and decreases cesarean delivery rates."
  (Steve Brown, 03:38)

2. Acute Migraine Headache Treatment

[04:04–08:25]

• Prevalence:
  • “Migraines affect about 15% of the population, with women being disproportionately affected.” (Valeria Vasquez, 04:14)
• Diagnosis Tools:
  • POUND mnemonic: Pulsatile, One-day, Unilateral, Nausea, Disability
    • Three or more = likely migraine; four or five = very high specificity (PLR 24)
  • SNOOP10 mnemonic to rule out secondary causes
• Severity Assessment:
  • MIDAS questionnaire for stratified management
• Treatment Algorithm:
  • Mild migraines (MIDAS 1–2): NSAIDs, simple analgesics
  • Moderate–Severe (MIDAS 3–4):
    • First line: Triptans
    • Second line: Gepants (ubrogepant, rimegepant—good for CV risk but costly), Ditans (lasmiditan—sedation risk, driving restriction)
    • Parenteral options: For refractory cases (IV dihydroergotamine, ketorolac)
• Special Populations:
  • Children: Start with lifestyle and simple analgesics; triptans if >6 years
  • Older adults: Be cautious with NSAIDs/triptans; consider gepants/ditans
  • Pregnant patients: Acetaminophen with caffeine preferred; triptans only if benefits outweigh risks; avoid in 1st trimester; no gepants/ditans
• Additional Approaches:
  • Neuromodulation (FDA-approved devices), occipital nerve blocks
  • Lifestyle: Triggers to avoid (odors, smoke), improve sleep
• Quote:

  "About one third of patients don’t respond well to their first triptan, so it’s crucial to try a different one if necessary."
  (Valeria Vasquez, 06:07)

3. Tirzepatide for Obstructive Sleep Apnea

[08:25–10:46]

• Clinical Question: Is tirzepatide (Zepbound) effective for OSA?
• Key Study Data:
  • Phase 3 RCTs in adults with moderate–severe OSA, with and without PAP therapy
  • Outcome:
    • Reduction in apnea-hypopnea index (AHI) by ~20 points
    • Average 16–17% weight loss in obese patients
  • Effectiveness: Significant improvement only in patients with obesity, not in those with diabetes
• Quote:

  "Tirzepatide seems to work by addressing one of the root causes of obstructive sleep apnea, obesity."
  (Satyam Patel, 10:07)

• Takeaway: Tirzepatide is a valuable adjunct for OSA management in obese patients, particularly with weight loss.

4. Options for Unintended Pregnancy

[11:22–14:54]

• Prevalence: Still persistent issue, though overall pregnancy rates have declined 12% over 10 years
• Clinical Steps:
  • Confirm pregnancy first
  • Motivational interviewing to gauge patient goals and feelings
• All-Options Counseling:
  • Continue pregnancy (and parent)
  • Continue pregnancy (and adoption)
  • Medical or procedural abortion
• Impact of Legislation:
  • Post-Roe v. Wade, many states have enacted abortion bans
  • Telemedicine for abortion is increasing in regions with limited access
    • "For every 100 mile increase in distance to an abortion facility, there was a 60% increase in online requests for abortion medications." (Valeria Vasquez, 12:45)
• Clinical Resources:
  • Table 2 in the referenced AFP article for counseling, state law overviews
  • AAFP's Neighborhood Navigator for local support resources
• Medical Management:
  • Confirm intrauterine pregnancy (rule out ectopic)
  • Check Rh status; give Rhogam if indicated
  • Mifepristone + misoprostol increases success (92–99% effective at home in 1st trimester)
  • Procedural abortion is 99% effective; preferred in 2nd trimester
• Quote:

  "Abortion is safe, effective and it does not affect future conception or fertility."
  (Satyam Patel, 13:43)

• Role of Clinician: Stay unbiased, support patient choices, and be well-versed in all care options.

5. Artificial Intelligence Scribes in Healthcare

[14:54–16:43]

• Current Trends:
  • 38% of physicians are now using AI in practice
  • Scribe tools offer ambient listening, note generation, coding, and order suggestions
• Key Challenges:
  • Accuracy is the chief concern; claims of 90–99% but no robust comparative studies
  • Costs: $200–400/month per user; trustworthiness and acceptance remain in question
• Resources:
  • Table comparison of 8 AI scribe vendors in the AFP article
  • Additional tips in March/April 2025 Family Practice Management (FPM)
• Quote:

  “If you start to save time with an AI scribe, don’t be tempted to schedule more patients. Consider other options to protect your well-being like going home earlier.”
  (Satyam Patel, 16:30)

6. Testosterone Replacement for Sexual Dysfunction (without Hypogonadism)

[16:43–19:22]

• Review Source: 43 RCTs, >11,000 men, ages 40+
• Definitions: Sexual dysfunction = acquired decreased libido or erectile dysfunction—not attributed to confirmed hypogonadism
• Efficacy Endpoints: Erectile dysfunction, sexual quality of life
• Findings:
  • Short term (3–12 months): No significant difference between testosterone and placebo
  • Long term (12–24 months): Evidence is low-certainty, unclear benefit
  • Adding testosterone to PDE5 inhibitors (e.g., sildenafil) doesn't improve outcomes vs. PDE5i alone
• Concerns:
  • Nearly half the studies were pharma-funded; exclusion of patients with comorbidities/psychiatric disease limits generalizability
• Guidelines:
  • Only use testosterone therapy in those with documented hypogonadism, per AUA and Endocrine Society guidelines
• Quote:

  "In men with only sexual dysfunction without any known testosterone deficiency, there's no benefit of testosterone replacement therapy over placebo in the short term."
  (Satyam Patel, 19:04)

• Overall Recommendation:
  • "Medicine by the Numbers" rating is yellow—for uncertain benefit

Memorable Moments & Notable Quotes

• “GLPs for everything.” (Steve Brown, 10:46)
• “Wow, that’s pretty high.” [On AI adoption in practice] (Steve Brown, 15:38)
• “Please rate and comment wherever you get your podcasts… Escúchanos en español en Revista America AFP.” (Outro, 19:34)

Timestamps for Major Segments

• Labor Management Guidelines: 00:34–04:02
• Acute Migraine Headache: 04:04–08:25
• Tirzepatide for Sleep Apnea: 08:25–10:46
• Unintended Pregnancy Options: 11:22–14:54
• AI Scribes in Health Care: 14:54–16:43
• Testosterone Replacement in Sexual Dysfunction: 16:43–19:22

Tone and Language

• The episode is informative, evidence-focused, and conversational, with a mix of clinical pearls, guidelines, and practical advice. The hosts frequently reference their own clinical experiences and maintain an approachable, sometimes humorous, tone throughout: “Good job on the Japants on the first take there. That was well done.” (Steve Brown, 06:32)

Summary Takeaway

This episode of the AFP Podcast delivers concise, actionable updates on practical clinical topics—equipping family physicians with evidence-based strategies for labor and delivery, migraine, sleep apnea, reproductive options, technology in practice, and men’s health. The discussions stress shared decision-making, up-to-date practice guidelines, and the evolving digital landscape in family medicine.